StockData
Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc. (CODX) stock

CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.28−0.01 (-3.78%)

Close on Nov 11, 2026Market cap $1.74MP/E –Yield –

Co-Diagnostics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Co-Diagnostics's total debt was $3.82M at Dec 31, 2018. For fiscal 2018 it was $3.82M, up 1274.4% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2018Dec 31, 2018$3.82M+1274.4%
FY2017Dec 31, 2017$277.73K-90.7%
FY2016Dec 31, 2016$3.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2018Dec 31, 2018$3.82M+27.2%
Q4 FY2017Dec 31, 2017$277.73K–
Q3 FY2017Sep 30, 2017$41.59K–
Q2 FY2017Jun 30, 2017$2.68M–
Q4 FY2016Dec 31, 2016$3.00M–

More Co-Diagnostics figures

See a number that looks wrong?